Millions of Australians struggle with chronic, persistent low back pain. When conservative remedies fail to relieve pain, many patients are faced with an unsettling future – escalating use of pain medications, major spine surgery, or continued suffering.
If you’re living with chronic low back pain, you may qualify for a new clinical research study. The study is for the Réjuve® micro-invasive injection, designed to provide long-term relief of low back pain. Participants in the study will receive care from a local doctor, and do not require a referral.
While nearly everyone experiences occasional back pain, chronic low back pain is different – and is often caused by a degraded disc in the lower spine. This can put pressure on nearby nerves, causing pain. Many people with a degraded disc experience continuous, yet tolerable pain that occasionally flares up for a few days or more. Although symptoms can vary, they generally include:
Right now, doctors at select centres in Australia are conducting a new clinical study for people with low back pain. The study is for Réjuve®, an investigational, micro-invasive injection designed to provide long-term relief of low back pain. The Réjuve procedure involves two separate injections for each disc that is being treated. Rather than simply mask pain, Réjuve is intended to repair the degraded disc, strengthen the disc’s tissue, and stabilize the spinal joint. This clinical study will examine whether Réjuve achieves these intended outcomes.
If you’re living with chronic low back pain, you may qualify for a new clinical study. The study is for the Réjuve® micro-invasive injection, designed to provide long-term relief of low back pain. If you qualify and choose to join the study, you will receive:
See If You Qualify
To see if you might qualify, and to get connected with your local study centre to learn more, please take the questionnaire below.